Reply to Volkman et al. Comment on "Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434"

被引：0
作者：
Kohli, Michele [1 ]
Joshi, Keya [2 ]
Beck, Ekkehard [2 ]
Hagiwara, Yuriko [3 ]
Van de Velde, Nicolas [2 ]
Igarashi, Ataru [4 ]
机构：
[1] Quadrant Hlth Econ Inc, 92 Cottonwood Crescent, Cambridge, ON N1T 2J1, Canada
[2] Moderna Inc, 325 Binney St, Cambridge, MA 02142 USA
[3] Moderna Inc, 4-1-1 Toranomon,Kamiyacho,Minato Ku, Tokyo 1056923, Japan
[4] Univ Tokyo, Grad Sch Pharmaceut Sci, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
来源：
VACCINES | 2024年 / 12卷 / 10期
关键词：
coronavirus; SARS-CoV-2; Japan; COVID-19; vaccination; cost-effectiveness;
D O I：
10.3390/vaccines12101175
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 42 条
  • [11] Comment on Cheng et al.'s "Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders"
    Chu, Wei -Min
    Ho, Hsin-En
    Wei, James Cheng-Chung
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 115 : 333 - 334
  • [12] Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure"
    Fedson, David S.
    Opal, Steven M.
    Rordam, Ole Martin
    MBIO, 2020, 11 (03):
  • [13] Response to Comment on Marchand et al. Type 1 diabetes onset triggered by COVID-19; and follow-up of the case
    Lucien Marchand
    Cédric Luyton
    Acta Diabetologica, 2021, 58 : 1285 - 1286
  • [14] Response to Comment on Marchand et al. Type 1 diabetes onset triggered by COVID-19; and follow-up of the case
    Marchand, Lucien
    Luyton, Cedric
    ACTA DIABETOLOGICA, 2021, 58 (09) : 1285 - 1286
  • [15] Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubikova et al.
    Galassi, Giuliana
    Marchioni, Alessandro
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (01) : E5 - E6
  • [16] Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand"
    Eubank, S.
    Eckstrand, I
    Lewis, B.
    Venkatramanan, S.
    Marathe, M.
    Barrett, C. L.
    BULLETIN OF MATHEMATICAL BIOLOGY, 2020, 82 (04)
  • [17] Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand”
    S. Eubank
    I. Eckstrand
    B. Lewis
    S. Venkatramanan
    M. Marathe
    C. L. Barrett
    Bulletin of Mathematical Biology, 2020, 82
  • [18] Clinical Science Can Address Rising Eating Disorder Psychopathology During the COVID-19 Pandemic: Comment on Gruber et al. (2020)
    Christensen, Kara A.
    Hagan, Kelsey E.
    Forbush, Kelsie T.
    AMERICAN PSYCHOLOGIST, 2022, 77 (01) : 140 - 142
  • [19] Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874
    Cinar, Olgu Erkin
    Erdogdu, Batuhan
    Karadeniz, Mine
    Unal, Sercan
    Malkan, Umit Yavuz
    Goker, Hakan
    Haznedaroglu, Ibrahim Celalettin
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [20] No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024, 31, 3579-3590
    Nocini, Riccardo
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    CURRENT ONCOLOGY, 2024, 31 (10) : 6267 - 6269
12345